METACARE CO., Ltd. (KRX:118000)
South Korea · Delayed Price · Currency is KRW 243.00
+2.00 (0.83%)
At close: Mar 18, 2026
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 41.4 billion as of March 18, 2026. Its market cap has decreased by -23.87% in one year.
Market Cap
41.40B
Enterprise Value
99.68B
Revenue
28.10B
Ranking
n/a
PE Ratio
32.36
Stock Price
243.00
Market Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has increased from 39.82B to 41.40B, an increase of 3.97%. That is a compound annual growth rate of 0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 41.40B | -20.98% |
| Dec 30, 2025 | 52.39B | 12.75% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.46T |
| Celltrion | 45.09T |
| ALTEOGEN | 18.96T |
| Sam Chun Dang Pharm. | 17.19T |
| IVIM Technology | 58.97B |
| Aprogen Biologics | 54.93B |
| Tdspharm | 52.98B |
| EOFLOW | 51.11B |